cefsulodin and Pneumonia

cefsulodin has been researched along with Pneumonia* in 4 studies

Other Studies

4 other study(ies) available for cefsulodin and Pneumonia

ArticleYear
[Clinical and pharmacokinetic evaluation of cefsulodin in neonates and young infants].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:12

    Four neonates and young infants were treated with cefsulodin (CFS) at doses ranging from 20-25 mg/kg every 6 hours for 6.25 to 17 days, and clinical efficacy and side effects were evaluated. Among the 4 infants with bacterial infections including meningitis, bronchitis and pneumonia, the results were good in 2 patients with meningitis, but unknown in 2 patients because of additional use of gentamicin. One of the 4 patients had eosinophilia. Minimal inhibitory concentrations of CFS against 4 isolates of Pseudomonas aeruginosa were 1.56 against one and 12.5 micrograms/ml against other 3 strains with an inoculum size of 10(3) CFU. Serum concentrations of CFS were measured in one- and four-month-old infants upon 25.3 and 20.9 mg/kg bolus intravenous injection of the antibiotic, respectively. The values were 36.4 and 33.4 at 30 minutes, and 5.1 and 3.2 micrograms/ml at 6 hours after injection, respectively. Serum half-lives were 1.89 and 1.69 hours, respectively. Total body clearances and volume distributions were 3.16 and 3.76 ml/min/kg, and 519.0 and 551.2 ml/kg, respectively.

    Topics: Bronchitis; Cefsulodin; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Pneumonia; Pseudomonas aeruginosa; Staphylococcus aureus

1989
[Pharmacokinetics and clinical studies on cefsulodin in neonates].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:12

    Pharmacokinetics and clinical studies on cefsulodin (CFS) were conducted in neonates. 1. MIC's of CFS, sulbenicillin and gentamicin (GM) were determined using 7 strains of Pseudomonas aeruginosa clinically isolated from neonates and maintained as stock cultures. CFS was found to be nearly as active as GM. 2. When CFS 20 mg/kg was administered to a 12-day-old neonate by intravenous bolus injection, serum concentrations were 8.7 micrograms/ml before administration and 51.7 micrograms/ml at 30 minutes, 44.4 micrograms/ml at 1 hour, 38.6 micrograms/ml at 2 hours and 11.1 micrograms/ml at 6 hours after administration. The half-life was 2.5 hours. 3. CFS was administered alone or combination with other drugs to 3 neonates. The drug was clinically effective in 2 cases and slightly effective in another. Bacteriologically, one case was rated as decreased, another as replaced, and the remaining one as unchanged. 4. Neither side effects nor abnormal laboratory values attributable to CFS were found.

    Topics: Cefsulodin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Otitis Media; Pneumonia; Pseudomonas aeruginosa

1989
Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs.
    The Journal of infectious diseases, 1982, Volume: 146, Issue:4

    Topics: Animals; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Guinea Pigs; Moxalactam; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin

1982
[Laboratory and clinical studies on cefsulodin (author's transl)].
    The Japanese journal of antibiotics, 1981, Volume: 34, Issue:10

    Laboratory and clinical studies on cefsulodin (CFS), a new antipseudomonal cephalosporin antibiotic, were carried out and the following results were obtained. 1. The MIC of CFS against P. aeruginosa showed the peak of susceptibility at 3.13 mcg/ml in the inoculum size of 10(8) cells/ml and at 1.56 mcg/ml in the inoculum size of 10(8) cells/ml. It has a higher superiority as compared with gentamicin or piperacillin and gentamicin-resistant strains of P. aeruginosa were sensitive to CFS. 2. CFS was given to 3 patients with acute pneumonia and 5 patients with chronic cystitis which were all due to P. aeruginosa. Clinical effects were good in 2 patients and poor in a patient with acute pneumonia, and those were good in 3 patients and poor in 2 patients with chronic cystitis. Side effects were not recognized at all.

    Topics: Adult; Aged; Cefsulodin; Cephalosporins; Cystitis; Drug Evaluation; Female; Gentamicins; Humans; Male; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections

1981